SPRC

SciSparc Ltd.

Nasdaq · Pharmaceutical Preparations · Inc. L3 · CIK 0001611746
$4.27 +1.67% $2.4M
Vol
Market Cap$2.4M
Cap SizeNano Cap
Reddit Sentiment67° Warm
Press Releases3
Exchange Nasdaq·Sector Pharmaceutical Preparations·Inc. L3·CIK 0001611746·Prev Close $4.20

No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
2024-12-31
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

67°
Warm
Bearish Neutral Bullish
2 mentions 2 bullish 0 bearish 2 time periods

Reddit Sentiment History

DateMentionsSentimentBullishBearishThreads
May 1, 2026160° Warm101
Apr 30, 2026160° Warm101

Recent Reddit Threads

r/stockmarket Bullish 23d 3h ago
Cannabinoid Clinical Trials Gain Momentum: (IGC, SPRC, and more)
▲ 1 💬 0 ⚡ 0.5
Apr 23, 2026
short_interest
FTD: SPRC — 108,113 shares ($0.7M) failed to deliver
Settlement: 20260423, Price: $6.12, FTD Value: $661,651.56, SCISPARC LTD ORD SHS COM NEW 2
Apr 22, 2026
short_interest
FTD: SPRC — 203,841 shares ($1.2M) failed to deliver
Settlement: 20260422, Price: $5.99, FTD Value: $1,221,007.59, SCISPARC LTD ORD SHS COM NEW 2
Apr 21, 2026
short_volume
Short Volume: SPRC — 56.0% short (1.3M / 2.3M)
Short: 1,305,491 | Exempt: 5,418 | TRF Vol: 2,329,946 | Short Ratio: 56.0% | Off-exchange volume (dark pool + OTC)
Mar 16, 2026
announcement
SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy
<p align="justify">TEL AVIV, Israel, March 16, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced tha
Mar 12, 2026
announcement
SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
<p align="justify">TEL AVIV, Israel, March 12, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that
Mar 10, 2026
m_and_a
SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails
<p>TEL AVIV, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Lab